Very high cycle fatigue of copper: Evolution, morphology and locations of surface slip markings

The surfaces of commercially pure polycrystalline copper specimens subjected to interrupted 20 kHz fatigue tests in the very high cycle fatigue regime were investigated. The stress amplitude needed to form the early slip markings was found twice lower than the stress amplitude required to fracture which confirmed the results obtained by Stanzl-Tschegg et al. (2007). Three types of slip markings were classified according to their morphology and their location in the polycrystalline material. They are compared to slip markings observed during fatigue tests at frequencies lower than 100 Hz and numbers of cycles lower than 107. For 20 kHz fatigue tests, stress amplitudes ranging from 45 MPa to 65 MPa produce straight and long early persistent slip markings located along twin boundaries. Stress amplitudes lower than 45 MPa produce clusters of fine early persistent slip markings mainly located at triple junctions

Evaluating Schmid criterion for predicting preferential locations of persistent slip markings obtained after very high cycle fatigue for polycrystalline pure copper

Very high cycle fatigue carried out on pure copper polycrystals promotes early slip markings, labelled as slip markings of types II and III, localized close to grain or twin boundaries. In this work, we focus on whether Schmid criterion can predict the preferential sites of slip markings of types II and III and identify the active slip systems. Combining observations of slip markings and polycrystalline modeling, it is shown that considering pure cubic elastic behavior, maximum resolved shear stress as a criterion for type II slip markings preferential sites is 70% reliable criterion. Concerning slip markings of type III, the reliability falls to 30%. The role of cross slip is highlighted and a scenario rationalizing the stress amplitude conditions and sites to observe early slip markings of type II or III for copper polycrystals is proposed

Improving Multi-task Learning via Seeking Task-based Flat Regions

Multi-Task Learning (MTL) is a widely-used and powerful learning paradigm for training deep neural networks that allows learning more than one objective by a single backbone. Compared to training tasks separately, MTL significantly reduces computational costs, improves data efficiency, and potentially enhances model performance by leveraging knowledge across tasks. Hence, it has been adopted in a variety of applications, ranging from computer vision to natural language processing and speech recognition. Among them, there is an emerging line of work in MTL that focuses on manipulating the task gradient to derive an ultimate gradient descent direction to benefit all tasks. Despite achieving impressive results on many benchmarks, directly applying these approaches without using appropriate regularization techniques might lead to suboptimal solutions on real-world problems. In particular, standard training that minimizes the empirical loss on the training data can easily suffer from overfitting to low-resource tasks or be spoiled by noisy-labeled ones, which can cause negative transfer between tasks and overall performance drop. To alleviate such problems, we propose to leverage a recently introduced training method, named Sharpness-aware Minimization, which can enhance model generalization ability on single-task learning. Accordingly, we present a novel MTL training methodology, encouraging the model to find task-based flat minima for coherently improving its generalization capability on all tasks. Finally, we conduct comprehensive experiments on a variety of applications to demonstrate the merit of our proposed approach to existing gradient-based MTL methods, as suggested by our developed theory.Comment: 29 pages, 11 figures, 6 table

Effets dissipatifs en fatigue : étude de l'influence de la fréquence de sollicitation

Ce travail vise à caractériser la nature des effets dissipatifs produits lors d’essais de fatigue dans les matériaux métalliques pour des niveaux de contrainte inférieurs à la limite macroscopique d’élasticité. L’exposé présente deux dispositifs de sollicitation en fatigue. Le matériau étudié est un cuivre pur. Le premier dispositif comprend une machine hydraulique traditionnelle fonctionnant à des fréquences de quelques dizaines de Hertz. Le second système exploite le phénomène de résonance et permet d’effectuer des essais dynamiques à une fréquence de 20 kHz. Dans les 2 cas, un dispositif thermographique est utilisé pour mesurer des champs de température à la surface de l’échantillon. L’exploitation des champs permet alors d’accéder aux sources de chaleur et plus particulièrement, à la dissipation intrinsèque. Une méthode de traitement d’image ainsi qu’une forme d’équation de diffusion de la chaleur, adaptée à chacune des situations, sont présentées. Les énergies dissipées par cycle, issues des deux types d’essais, sont finalement montrées. Ces premiers résultats mettent en évidence une quasi-indépendance de cette énergie en fonction de la fréquence, illustrant un comportement indépendant de la vitesse de déformation

Autologous Transplantation of Adipose-Derived Stem Cells to Treat Acute Spinal Cord Injury: Evaluation of Clinical Signs, Mental Signs, and Quality of Life

BACKGROUD: Spinal cord injury (SCI) is damage that can cause a temporary or permanent change in spinal cord functions AIM: This work evaluates clinical signs, mental signs, and quality of life (QoL) after autologous adipose-derived stem cells (ADSCs) transplantation to treat acute spinal cord injury (SCI). MATERIAL AND METHODS: In this study, 47 SCI patients were recruited and divided into two groups: intervention and control. ADSCs were isolated and cultured under the cell culture quality control procedure. All patients in both groups underwent neurosurgery with or without ADSC transplantation. The recovery regarding neurological muscle, QoL, neurogenic bladder, and mental improvement was assessed after transplantation. RESULTS: All patients had improved in terms of motor function, bladder function, and daily living. No patients reported any side effect. MRI imaging showed significant changes in the lesion length of the spinal canal and the thickening of the spinal cord. Mental improvement was highest at six months after transplantation and lowest at one month after transplantation. The proportion of patients whose quality of life improved after treatment was 100%, while 80% of patients were satisfied with treatment outcomes. CONCLUSIONS: Thus, our data suggested that ADSCs transplantation was safe and effective for the treatment of SCI patients. Neurological muscle and neurogenic bladder were improved significantly after transplantation

Antibiotic use and prescription and its effects on Enterobacteriaceae in the gut in children with mild respiratory infections in Ho Chi Minh City, Vietnam. A prospective observational outpatient study.

BACKGROUND AND OBJECTIVES: Treatment guidelines do not recommend antibiotic use for acute respiratory infections (ARI), except for streptococcal pharyngitis/tonsillitis and pneumonia. However, antibiotics are prescribed frequently for children with ARI, often in absence of evidence for bacterial infection. The objectives of this study were 1) to assess the appropriateness of antibiotic prescriptions for mild ARI in paediatric outpatients in relation to available guidelines and detected pathogens, 2) to assess antibiotic use on presentation using questionnaires and detection in urine 3) to assess the carriage rates and proportions of resistant intestinal Enterobacteriaceae before, during and after consultation. MATERIALS AND METHODS: Patients were prospectively enrolled in Children's Hospital 1, Ho Chi Minh City, Vietnam and diagnoses, prescribed therapy and outcome were recorded on first visit and on follow-up after 7 days. Respiratory bacterial and viral pathogens were detected using molecular assays. Antibiotic use before presentation was assessed using questionnaires and urine HPLC. The impact of antibiotic usage on intestinal Enterobacteriaceae was assessed with semi-quantitative culture on agar with and without antibiotics on presentation and after 7 and 28 days. RESULTS: A total of 563 patients were enrolled between February 2009 and February 2010. Antibiotics were prescribed for all except 2 of 563 patients. The majority were 2nd and 3rd generation oral cephalosporins and amoxicillin with or without clavulanic acid. Respiratory viruses were detected in respiratory specimens of 72.5% of patients. Antibiotic use was considered inappropriate in 90.1% and 67.5%, based on guidelines and detected pathogens, respectively. On presentation parents reported antibiotic use for 22% of patients, 41% of parents did not know and 37% denied antibiotic use. Among these three groups, six commonly used antibiotics were detected with HPLC in patients' urine in 49%, 40% and 14%, respectively. Temporary selection of 3rd generation cephalosporin resistant intestinal Enterobacteriaceae during antibiotic use was observed, with co-selection of resistance to aminoglycosides and fluoroquinolones. CONCLUSIONS: We report overuse and overprescription of antibiotics for uncomplicated ARI with selection of resistant intestinal Enterobacteriaceae, posing a risk for community transmission and persistence in a setting of a highly granular healthcare system and unrestricted access to antibiotics through private pharmacies. REGISTRATION: This study was registered at the International Standard Randomised Controlled Trials Number registry under number ISRCTN32862422: http://www.isrctn.com/ISRCTN32862422

Assessing the efficacy and safety of magnesium sulfate for management of autonomic nervous system dysregulation in Vietnamese children with severe hand foot and mouth disease.

BACKGROUND: Brainstem encephalitis is a serious complication of hand foot and mouth disease (HFMD) in children. Autonomic nervous system (ANS) dysregulation and hypertension may occur, sometimes progressing to cardiopulmonary failure and death. Vietnamese national guidelines recommend use of milrinone if ANS dysregulation with Stage 2 hypertension develops. We wished to investigate whether magnesium sulfate (MgSO4) improved outcomes in children with HFMD if used earlier in the evolution of the ANS dysregulation (Stage 1 hypertension). METHODS: During a regional epidemic we conducted a randomized, double-blind, placebo-controlled trial of MgSO4 in children with HFMD, ANS dysregulation and Stage 1 hypertension, at the Hospital for Tropical Diseases in Ho Chi Minh city. Study participants received an infusion of MgSO4 or matched placebo for 72 h. We also reviewed data from non-trial HFMD patients in whom milrinone failed to control hypertension, some of whom received MgSO4 as second line therapy. The primary outcome for both analyses was a composite of disease progression within 72 h - addition of milrinone (trial participants only), need for ventilation, shock, or death. RESULTS: Between June 2014 and September 2016, 14 and 12 participants received MgSO4 or placebo respectively, before the trial was stopped due to futility. Among 45 non-trial cases with poorly controlled hypertension despite high-dose milrinone, 33 received MgSO4 while 12 did not. There were no statistically significant differences in the composite outcome between the MgSO4 and the placebo/control groups in either study (adjusted relative risk (95%CI) of [6/14 (43%) vs. 6/12 (50%)], 0.84 (0.37, 1.92), p = 0.682 in the trial and [1/33 (3%) vs. 2/12 (17%)], 0.16 (0.01, 1.79), p = 0.132 in the observational cohort). The incidence of adverse events was similar between the groups. Potentially toxic magnesium levels occurred very rarely with the infusion regime used. CONCLUSION: Although we could not demonstrate efficacy in these studies, there were no safety signals associated with use of 30-50 mg/kg/hr. MgSO4 in severe HFMD. Intermittent outbreaks of HFMD are likely to continue across the region, and an adequately powered trial is still needed to evaluate use of MgSO4 in controlling hypertension in severe HFMD, potentially involving a higher dose regimen. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01940250 (Registered 22 AUG 2013). Trial sponsor: University of Oxford

Clinical evaluation of dengue and identification of risk factors for severe disease: protocol for a multicentre study in 8 countries

Background: The burden of dengue continues to increase globally, with an estimated 100 million clinically apparent infections occurring each year. Although most dengue infections are asymptomatic, patients can present with a wide spectrum of clinical symptoms ranging from mild febrile illness through to severe manifestations of bleeding, organ impairment, and hypovolaemic shock due to a systemic vascular leak syndrome. Clinical diagnosis of dengue and identification of which patients are likely to develop severe disease remain challenging. This study aims to improve diagnosis and clinical management through approaches designed a) to differentiate between dengue and other common febrile illness within 72 h of fever onset, and b) among patients with dengue to identify markers that are predictive of the likelihood of evolving to a more severe disease course. Method/Design: This is a prospective multi-centre observational study aiming to enrol 7–8000 participants aged ≥ 5 years presenting with a febrile illness consistent with dengue to outpatient health facilities in 8 countries across Asia and Latin America. Patients presenting within 72 h of fever onset who do not exhibit signs of severe disease are eligible for the study. A broad range of clinical and laboratory parameters are assessed daily for up to 6 days during the acute illness, and also at a follow up visit 1 week later. Discussion: Data from this large cohort of patients, enrolled early with undifferentiated fever, will be used to develop a practical diagnostic algorithm and a robust clinical case definition for dengue. Additionally, among patients with confirmed dengue we aim to identify simple clinical and laboratory parameters associated with progression to a more severe disease course. We will also investigate early virological and serological correlates of severe disease, and examine genetic associations in this large heterogeneous cohort. In addition the results will be used to assess the new World Health Organization classification scheme for dengue in practice, and to update the guidelines for “Integrated Management of Childhood Illness” used in dengue-endemic countries. Trial registration: NCT01550016. Registration Date: March 7, 201